Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...
The prospective, multicenter phase 2 RACE-IT trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
GLP-1RAs are associated with greater annualized total hip bone loss in patients without diabetes, driven primarily by weight loss.
The low-dose radiation therapy typically uses only a fraction of the radiation used to treat cancer. It is intended for ...
Hip replacement surgery, or hip arthroplasty, is a common procedure that can improve mobility and decrease pain in a hip joint that's no longer functioning properly. The American College ...
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...
aDepartment of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA bDepartment of Medicine Statistical Core, University of California, Los Angeles, Los Angeles, CA, USA ...
Kade Paterson receives funding from MRFF and ASICS for research unrelated to this article. He is also the president of Sports and Exercise Podiatry Australia. Rana Hinman receives funding from NHMRC, ...
Illustration: Kelsea Petersen / The Athletic; photos: Vince Bucci, Michael Loccsiano, Kevin C. Cox, Elsa / Getty Images No sport embodies hip-hop more than basketball. No music genre embodies ...
As we get older, one of the most common and debilitating issues for older adults is a lack of mobility in their hips. I’ve been a personal trainer for 35 years and have been running PT courses for the ...
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results